Patient and Disease Characteristics of the 500 Real-World Patients With Pulmonary Arterial Hypertension Treated With Selexipag
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Heart and Lung Transplantation